BILL · BILL Holdings, Inc. · Stock research

Current Thesis

BILL is a beaten-down B2B financial-operations platform (AP/AR automation, Divvy spend-and-expense, invoicing for SMBs) that got cut to ~$32 on a multi-year growth deceleration, and is now re-rating on a self-help turnaround. The Q3 FY2026 print (reported ~2026-05-07) delivered the first-ever GAAP-profitable quarter, a $1.0B buyback authorization, and a workforce cut of up to 30%. Price has responded: +40% from $31.96 (2026-06-22) to $44.66 (2026-07-17), pushing into the 200-day SMA at $49.42 as the natural resistance test. The leg is a margin/capital-return re-rate on a maturing business (12-13% top-line), not narrative velocity in the product. Tradeable while it holds the breakout, but this is a bounce reclaiming a downtrend, not a secular accelerating story. Next binary is the ~2026-08-26 Q4/FY print.

Bullish and bearish views on BILL Holdings, Inc.

The model's bull view on BILL Holdings, Inc. (BILL), in brief: Q3 FY2026 (reported ~2026-05-07): first GAAP-profitable quarter, GAAP net income $12.8M, non-GAAP net income $77.2M. The bear view: Growth is MATURING: FY2026 guide of $1,642-1,652M is only 12-13% YoY, a fraction of the 30-70% of prior cycles. Both cases follow in full.

Bull Case

• Q3 FY2026 (reported ~2026-05-07): first GAAP-profitable quarter, GAAP net income $12.8M, non-GAAP net income $77.2M. Core revenue $371.1M +16% YoY outgrew total revenue $406.6M +13% the subscription/transaction mix is compounding faster than the float-sensitive headline.
• $1.0B buyback authorized over 24 months (announced with Q3) against a ~$4.6B market cap (~$44.66 × ~103M shares) north of 20% of the float, a standing bid under the tape while cost cuts flow through.
• Up to 30% workforce reduction (announced Q3), $30-60M in charges an aggressive margin reset that the market is now pricing as operating leverage rather than a distress signal.
• Momentum structure is constructive: +40% off the 2026-06-22 low of $31.96, higher lows the whole way, short-term moving averages above long-term (buy configuration). Clear air to the 200-day at $49.42.
• Sell-side re-engaging: TD Cowen initiated Buy, PT $43 (2026-06-22) already exceeded; JPMorgan Overweight, PT $50; consensus Buy, average PT ~$54-59, high $84.

Bear Case

• Growth is MATURING: FY2026 guide of $1,642-1,652M is only 12-13% YoY, a fraction of the 30-70% of prior cycles. TPV +12% ($89B in Q3) across 493,800 businesses signals a saturating SMB installed base. This playbook prizes accelerating narrative BILL does not have one.
• Truist downgraded Buy Ramp, Brex, Melio, and Intuit are all pressing into AP/AR and spend management.
• The entire re-rate leans on cost-cut plus buyback mechanics. A 30% headcount reduction risks product velocity and net-new adds into FY2027 the easy margin is a one-time bank, not a recurring engine.
• Chasing straight into the resistance test without a pullback is late in the bounce.
• A slice of profitability is interest income on customer funds held; a Fed easing path pressures that line directly.

Setup & Price Structure

• Last ~$44.66 (2026-07-17). 200-day SMA $49.42 is the overhead magnet and the level that decides bounce-vs-trend.
• Reversal base: higher lows from $31-33 in June into the high $30s, then a breakout through ~$40 into the $40s. The $38-40 zone is the breakout shelf.
• 52-week range: mid-range well off the lows, far below prior-cycle highs.
• Stance: short-term MA above long-term (buy signal); RSI extended after the run, but there is no earnings binary inside the 30-day window to force a decision, so the extension is not a hard blocker.
• The leg to trade: continuation into $49.42; a clean reclaim opens the low $50s (JPM PT $50, consensus ~$54-59). Loss of $38-40 ends it.

Catalyst Calendar (next 30 days)

• ~2026-08-26 (est., just beyond 30d): Q4 + FY2026 earnings. Q4 guide: total revenue $425-435M (+11-13%), core revenue $392-402M (+13-16%); FY non-GAAP EPS guide $2.61-2.64. The binary that proves or breaks the operating-leverage story.
• Ongoing: $1.0B buyback execution; expect a blackout pause into the late-August print.
• No FDA/PDUFA and no dated analyst day inside 30 days. Fed rate-path headlines move the float-income line indirectly.

What Would Change Our Mind

• A weekly close below $38 loses the breakout shelf and breaks the June-low reversal structure the re-rate leg is finished; stand aside for a fresh base.
• A weekly close below $32 marks full turnaround failure back into the prior downtrend.
• At the ~2026-08-26 print, core-revenue growth decelerating under ~13% or TPV growth under ~10% confirms the MATURING read and removes the reason to hold the bounce.
• A reclaim and hold above the 200-day ($49.42) flips this from bounce to trend that is upside confirmation, not an invalidation.

Correlation Notes

• Peer complex: Ramp and Brex (private), Melio, Intuit (QuickBooks Bill Pay), AvidXchange, Coupa B2B AP/AR plus spend automation. Intuit and AvidXchange prints are the cleanest reads on SMB-payments demand tone.
• Rate sensitivity: float income on customer funds ties part of profitability to the short end; a dovish Fed is a headwind to that line even as it lifts risk-on multiples.
• Beta: high-beta fintech/software that trades with the IGV complex. The 2026-07-15 memory-chip-led Nasdaq selloff is the tape reminder a broad risk-off unwinds beaten-down-fintech bounces first.
• Theme-tag correction: the prior "fintech-consumer-credit" label is a mis-fit; BILL is B2B SMB financial-operations automation, not consumer credit.